HIV-associated nephropathy

Michael J. Ross, Paul E. Klotman

Research output: Contribution to journalReview articlepeer-review

62 Scopus citations


HIVAN is the most common cause of chronic renal failure in HIV-1 seropositive patients and disproportionately affects patients of African descent. Patients with HIVAN are typically diagnosed late in the course of their HIV illness when they present with renal insufficiency and proteinuria. HIV-1 infection of renal epithelial cells has been shown to be crucial in the initiation of HIVAN pathogenesis. Furthermore, the kidney represents a reservoir where HIV-1 infection can persist despite treatment with HAART. Small clinical trials, case reports, and epidemiologic data strongly suggest a benefit of HAART in the treatment of HIVAN. Although not currently the standard, we recommend that the diagnosis of HIVAN be sought aggressively by physicians caring for HIV infected patients. And, when found, we also recommend that patients be started on HAART independent of their CD4 cell count and viral load.

Original languageEnglish (US)
Pages (from-to)1089-1099
Number of pages11
Issue number8
StatePublished - May 21 2004
Externally publishedYes


  • Epidemiology
  • HIV-1
  • HIV-associated nephropathy
  • Kidney
  • Pathogenesis
  • Treatment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases


Dive into the research topics of 'HIV-associated nephropathy'. Together they form a unique fingerprint.

Cite this